A detailed history of Clarius Group, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Clarius Group, LLC holds 13,680 shares of SRRK stock, worth $609,033. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,680
Previous 13,680 -0.0%
Holding current value
$609,033
Previous $113,000 3.54%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$7.84 - $16.79 $5,041 - $10,795
643 Added 4.93%
13,680 $113,000
Q1 2024

Apr 17, 2024

SELL
$13.2 - $17.76 $25,462 - $34,259
-1,929 Reduced 12.89%
13,037 $231,000
Q4 2023

Jan 29, 2024

BUY
$6.52 - $20.32 $97,578 - $304,109
14,966 New
14,966 $281,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.3B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.